The medical device industry in recent years, the average annual output value and the market growth rate in more than 20%, much higher than the average growth rate for the same period in the national economy, but only a 3% share of the medical equipment market in the world. Future industrial growth space is huge, technological innovation has become the largest direction of China's medical equipment industry, but also to build the value chain of high-end embodies.
Moment every industry innovation in the tech sector is highly active, by leaps and bounds, from materials, manufacturing, electronics, information, networks, and other advanced technology innovation is increasingly accelerated, innovative products continue to emerge. Medical device companies still have a long gorgeous transition road to the "medical" from "small devices" to accelerate the pace of innovation, continue to put efforts in need of medical device companies.
Innovation is the theme of the development of the medical device industry
China's medical equipment sector innovation capability is relatively weak, the imperfect innovation chain innovation strategy system does not build the whole industry supporting backward the research doctors combination does not close the technological monopoly of multinational corporations and local enterprises homogeneity of intensified competition, the clinical use a variety of factors, resulting in medical devices in China's overall level of developed countries there is a wide gap between the specific performance:
1, about 14,000 existing medical equipment manufacturing enterprises in China, although many companies, but about 80% of small-scale enterprises with annual sales of only a few hundred million, the same situation is "many, small, scattered" Although a wide variety, but the majority of the added value is low, at the low end of the medical device market, clearly showing the "low" phenomenon, namely: low technical content and low price. For example: a one-time infusion, medical tubing, sanitary materials, general surgery instruments. The low-end market competition has become a Red Sea, its profit margins are narrowing.
In addition to the policy factors, environmental factors, factors of supporting industries, intellectual property protection, and other factors, the majority of medical device companies, technology innovation inadequate investment, business is not high enough, innovation is weak, the innovative resources system not concentrate Heli, lack of technological innovation strategy planning and innovative strategies method: the products are more concentrated in the category of low value-added, technology-based high-end products is still mainly rely on imports.
3 multinational medical device companies to capture the market of high-end field, have obvious advantages, invest and build factories in China's rapid expansion, and is gradually sinking to the low-end market, attempting comprehensive coverage of high, medium and low-end field such as: Philips orientation in the low-end, high-end, Siemens is the main orientation, includes almost all kinds of conventional medical devices. This compares with our local medical device companies are still weak.
4, has the core technology will control the market mastership, such as: GE, Siemens Enterprise has a large number of independent intellectual property rights, and international standards, rules and technical platform. Domestic high-end products still imitation, improved main key parts are still dependent on imports, the number of producers are numerous, but the overall research, scale, brand competitiveness is relatively weak, especially the lack of core technology.
5, the hospital distribution channels is a lack of transparency, high degree of market enterprises to focus more on the establish hospitals relations, rather than to improve the product quality and performance, which affected the healthy development of the enterprise itself and the industry as a whole.
6, technical standards and standards for medical devices innovation, product innovation a core scale. Although China is a member of the International Medical Equipment Organization for Standardization, but in the lack of status and say in the formulation of international medical equipment technical standards.
7, World Electrotechnical Commission (IEC), the set 6 Medical Equipment Standardization Technical Committee Chairman and the Secretary-General served by medical academics, research institutes and scholars of the United States or European countries, and the manufacturer's engineering and technical personnel. Obviously, you want to participate in international competition, so that more medical equipment to the world, we must start from the innovation.
8, today, most of the artificial joints used in hospitals in China are Johnson & Johnson, Zimmer and Smith & Nephew foreign company's products, expensive, imported products are designed in accordance with the characteristics of European and American race bones, clinical applications does not match with the people bones and other issues.
9, in the diabetes medical device market, currently six major manufacturers occupy - Roche, Johnson & Johnson, Medtronic, Bayer, Abbott, American BD Company diabetes medical device market they occupy nearly 90% market share. Our local medical device companies need to continue to put efforts in this area.
10 CT machine market monopolized by a handful of multinational companies, the CT machine customers can choose there is little room for bargaining power is low, high procurement cost of the CT parts, the total cost is therefore difficult to reduce drastically, even low The end product, its price is also more than $ 200,000. This case to a certain extent affect the universal application of CT machine in grassroots medical institutions in China.
11, medical devices and equipment in multiple areas, multinationals brand occupies. More than 80% of the buyers in the purchase of medical equipment preferred multinationals products, and Universal, Philips, Siemens has won the leading position in most market segments, and supplies in the area, orthopedics, drug-eluting stents, Medtronic, Johnson & Johnson, and the history of Prosecco is in the leading position.